S D Rybalkin1, K E Bornfeldt. Show Affiliations » 1. Department of Pharmacology, University of Washington, Seattle 98195-7470, USA.
Abstract
Entities: Species
Mesh： See more » 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors3',5'-Cyclic-AMP Phosphodiesterases/physiology3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors3',5'-Cyclic-GMP Phosphodiesterases/physiologyAorta/cytologyAorta/physiologyArteries/cytologyArteries/physiologyCell Cycle/physiologyCell Division/drug effectsCell Division/physiologyCyclic AMP/physiologyCyclic GMP/physiologyCyclic Nucleotide Phosphodiesterases, Type 1Cyclin GCyclin G1CyclinsGene ExpressionHumansMuscle, Smooth, Vascular/cytologyMuscle, Smooth, Vascular/physiologyPhosphodiesterase Inhibitors/pharmacologyPhosphoric Diester Hydrolases/geneticsPhosphoric Diester Hydrolases/physiologySignal Transduction/physiology
Substances： See more » CCNG1 protein, humanCyclin GCyclin G1CyclinsPhosphodiesterase InhibitorsCyclic AMPPhosphoric Diester Hydrolases3',5'-Cyclic-AMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 13',5'-Cyclic-GMP PhosphodiesterasesCyclic GMP
Year: 1999 PMID： 10605733
Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249